Jazz Pharmaceuticals plc: capex
| Value | {"amount": 26800000, "concept": "us-gaap:PaymentsToAcquirePropertyPlantAndEquipment", "currency": "USD"} |
|---|---|
| Period | 2025-01-01 – 2025-06-30 |
| Status | current |
| Entity | Jazz Pharmaceuticals plc |
Provenance
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
Retrieved: 2026-08-19T12:00:48.499087+02:00
Raw response sha256:
Also addressable by official identifiers:
Cite as: FACTANKER, https://factanker.com/fact/22a2719e-1f75-4324-96ed-9d8a01eea0d3
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
0001232524-26-000045 · Open the official SEC filing →Retrieved: 2026-08-19T12:00:48.499087+02:00
Raw response sha256:
f7bde1a401b286c74a2fd824ee1df541…Also addressable by official identifiers:
https://factanker.com/fact/sec/cik-0001232524/capex/2025-06-30 (CIK, metric, reporting date)Cite as: FACTANKER, https://factanker.com/fact/22a2719e-1f75-4324-96ed-9d8a01eea0d3
History
- supersedes {"amount": 26848000, "concept": "us-gaap:PaymentsToAcquirePropertyPlantAndEquipment", "currency": "USD"} (evidence 0001232524-25-000063)